INVESTIGATING NEURON-SPECIFIC ENOLASE AS A DIAGNOSTIC MARKER FOR EARLY DETECTION OF DIABETIC PERIPHERAL NEUROPATHY IN PATIENTS WITH TYPE II DIABETES MELLITUS. (2024). Journal of Population Therapeutics and Clinical Pharmacology, 31(9), 1095-1105. https://doi.org/10.53555/jb11kw29